Question of the Week

Question :
Posted On : 01 Feb 2007
I have a few patients with cardiomyopathy secondary to cardiac siderosis {B thal patients}. I am planning to start them on continuous infusion of desferral since they are in heart failure. What would be the method to do that?
4
Expert Answer :
No expert answer available.
Answer Discussion :
P
pediatriconcall
Profile
Deferoxamine 25-50 mg-kg over 8-12 hours as a subcutaneous infusion at least 5 nights per week is recommended. 2.5-3.0 gm is probably the maximal tolerated amount for subcutaneous infusion. Each 500 mg of Desferral should be diluted in a minimum of 2 ml preservative free water. DF should be given in areas with the most subcutaneous fat, such as the abdomen, thighs, upper arms, or buttocks. Infusion sites should be rotated to a different place each day. To avoid bone infections, thin individuals should avoid inserting the needle near bony prominences. The infusion needle should be inserted at a 45 degree angle.

Vitamin C {ascorbic acid} mobilizes iron from tissues. Doses More than 500 mg-day have been associated with worsening of cardiac dysfunction in patients with severe iron overload.
For heart involvement, intravenous desferral is recommended in the dose of 50mg-kg-day diluted in 50 cc normal saline given over 8 hours. Also give zinc and pyridoxien when giving desferral.

18 years ago
D
docpnp
Profile
Desferral 50mg-kg 5 days per week subcutaneous along with oral deferiprone{t.kelfer}50-75 mg-kg daily.
18 years ago
S
sangeeta kumar
Profile
intravenous infusion after diluting desferal in 10 Percent dextrose slowly over 8-10 hrs. 50mg-kg-day
18 years ago
K
kanta kumari
Profile
slow infusion over 10-12hrs if in hosp. or s-c infusion thro pump at home
18 years ago




Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0